News
Maxim Group Initiates Coverage On Alimera Sciences with Buy Rating, Announces Price Target of $10
25 Mar 24
News, Price Target, Initiation, Analyst Ratings
HC Wainwright & Co. Maintains Buy on Alimera Sciences, Raises Price Target to $6
8 Mar 24
News, Price Target, Analyst Ratings
Alimera Sciences Q4 EPS $(0.07) Up From $(0.54) YoY, Sales $26.31M Beat $24.34M Estimate
7 Mar 24
Earnings, News
Earnings Scheduled For March 7, 2024
7 Mar 24
Earnings
A Preview Of Alimera Sciences's Earnings
6 Mar 24
Earnings
The UK National Institute For Health And Care Excellence Issues Final Draft Guidance To Provide Patients With A Natural Lens Being Treated For Chronic Diabetic Macular Edema Access To ILUVIEN
8 Feb 24
Biotech, News, General